Lyell Immunopharma Inc

The current institutional shareholding score of Lyell Immunopharma Inc is 5.00, ranking 132 out of 386 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 57.58%, representing a quarter-over-quarter increase of 14.49%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.50% of shares outstanding, with 0.22% increase in holdings.